{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:20:46Z","timestamp":1782868846895,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mayocpiqo.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T07:34:50Z","timestamp":1597476890000},"page":"511-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study"],"prefix":"10.1016","volume":"4","author":[{"given":"Martin","family":"van Zyl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar E.","family":"Wysokinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Casanegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert D.","family":"McBane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mayocpiqo.2020.05.003_bib1","doi-asserted-by":"crossref","first-page":"S2230","DOI":"10.1016\/j.athoracsur.2003.09.002","article-title":"Mechanical heart valves: 50 years of evolution","volume":"76","author":"Gott","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"25","key":"10.1016\/j.mayocpiqo.2020.05.003_bib2","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.mayocpiqo.2020.05.003_bib3","first-page":"e521","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.05.003_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ejcts\/ezx324","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"52","author":"Falk","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2020.05.003_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.thromres.2014.02.031","article-title":"Mechanical heart valve prosthesis and warfarin: treatment quality and prognosis","volume":"133","author":"Grzymala-Lubanski","year":"2014","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2020.05.003_bib6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.thromres.2015.10.044","article-title":"INR variability and outcomes in patients with mechanical heart valve prosthesis","volume":"136","author":"Labaf","year":"2015","journal-title":"Thromb Res"},{"issue":"17","key":"10.1016\/j.mayocpiqo.2020.05.003_bib7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1002617","article-title":"Effect of home testing of international normalized ratio on clinical events","volume":"363","author":"Matchar","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.mayocpiqo.2020.05.003_bib8","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2020.05.003_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2020.05.003_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.mayocpiqo.2020.05.003_bib11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2020.05.003_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2020.05.003_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s11606-016-3700-8","article-title":"At-home versus in-clinic INR monitoring: a cost-utility analysis from The Home INR Study (THINRS)","volume":"31","author":"Phibbs","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"issue":"9508","key":"10.1016\/j.mayocpiqo.2020.05.003_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","article-title":"Self-monitoring of oral anticoagulation: a systematic review and meta-analysis","volume":"367","author":"Heneghan","year":"2006","journal-title":"Lancet"},{"issue":"9813","key":"10.1016\/j.mayocpiqo.2020.05.003_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(11)61294-4","article-title":"Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data","volume":"379","author":"Heneghan","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.05.003_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0003-4975(01)02656-X","article-title":"International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?","volume":"72","author":"Kortke","year":"2001","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2020.05.003_bib17","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0003-4975(01)03049-1","article-title":"Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients","volume":"72","author":"Sidhu","year":"2001","journal-title":"Ann Thorac Surg"},{"issue":"suppl 1 3","key":"10.1016\/j.mayocpiqo.2020.05.003_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1013228718768","article-title":"Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease","volume":"5","author":"Horstkotte","year":"1998","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2020.05.003_bib19","first-page":"1117","article-title":"A\u00a0randomized trial of patient self-managed versus physician-managed oral anticoagulation","volume":"20","author":"Sunderji","year":"2004","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.05.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-142-1-200501040-00006","article-title":"Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial","volume":"142","author":"Menendez-Jandula","year":"2005","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.05.003_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4065\/80.2.181","article-title":"Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs","volume":"80","author":"McBane","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.05.003_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1309\/DEK41W141Y0KRN8A","article-title":"Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers","volume":"130","author":"Karon","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.05.003_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A\u00a0method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.05.003_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.05.003_bib25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jtcvs.2014.01.004","article-title":"Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial","volume":"147","author":"Puskas","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.05.003_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.thromres.2014.06.007","article-title":"Thromboembolism, major bleeding and mortality in patients with mechanical heart valves: a population-based cohort study","volume":"134","author":"Labaf","year":"2014","journal-title":"Thromb Res"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820300953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820300953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:08:48Z","timestamp":1762870128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454820300953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2542454820300953"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.05.003","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}